2-Fluoro-3-nitrotoluene | CAS:437-86-5

We serve 2-Fluoro-3-nitrotoluene CAS:437-86-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
 2-Fluoro-3-nitrotoluene

Product Name: 2-Fluoro-3-nitrotoluene
Other Name: 2-Fluoro-1-methyl-3-nitrobenzene
CAS No: 437-86-5
MF: C7H6FNO2
MW: 155.12600
Density: 1.18g/cm3
Boiling point: 203.5ºC at 760mmHg
Refractive index: 1.53
Vapor Pressure: 0.0641mmHg at 25°C
UN Number: UN3286
UN Proper Shipping Name: FLAMMABLE LIQUID, TOXIC, CORROSIVE, N.O.S.
Transport hazard class: 3
Packing group: II
 
Specification
Appearance: Colorless to light yellow transparent liquid
Purity: ≥98%
Water: ≤0.5%
 
Application: Organic intermediates, pharmaceutical intermediates, agrochemical intermediates.
Package: 25kg/drum, packed in plastic drum or plastic coated iron drum.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.



Contact us for information like 2-Fluoro-3-nitrotoluene chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Fluoro-1-methyl-3-nitrobenzene physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Fluoro-1-methyl-3-nitrobenzene Use and application,2-Fluoro-1-methyl-3-nitrobenzene technical grade,usp/ep/jp grade.


Related News: Others wondered if this was a concerted effort to promote certain herbal products to boost their makers’ share prices ahead of the Chinese stock market’s re-opening Monday.N-(3-methyl-2,6-dihydro-1,3,5-oxadiazin-4-yl)nitramide manufacturer Others wondered if this was a concerted effort to promote certain herbal products to boost their makers’ share prices ahead of the Chinese stock market’s re-opening Monday.4-Amino-3-nitrophenol supplier Fate Therapeutics, Inc. recently announced new in vivo preclinical data for FT819, its first off-the-shelf, iPSC-derived chimeric antigen receptor (CAR) T-cell product candidate, at the 61st American Society of Hematology (ASH) Meeting and Exposition in Orlando, FL.potassium,5-methyl-1,3,4-oxadiazole-2-carboxylate vendor Fate Therapeutics, Inc. recently announced new in vivo preclinical data for FT819, its first off-the-shelf, iPSC-derived chimeric antigen receptor (CAR) T-cell product candidate, at the 61st American Society of Hematology (ASH) Meeting and Exposition in Orlando, FL.Fate Therapeutics, Inc. recently announced new in vivo preclinical data for FT819, its first off-the-shelf, iPSC-derived chimeric antigen receptor (CAR) T-cell product candidate, at the 61st American Society of Hematology (ASH) Meeting and Exposition in Orlando, FL.